|
|
| Nomenclature |
|
Symbol:
|
Hspg2tm1Rdgr
|
|
Name:
|
perlecan (heparan sulfate proteoglycan 2);
targeted mutation 1, Kathryn D Rodgers
|
|
MGI ID: |
MGI:3712962 |
|
Synonyms: |
C1532Yneo |
|
Gene:
|
Hspg2
Location:
Chr4:137468769-137570630 bp, + strand
Genetic Position: Chr4,
69.93 cM
|
|
Mutation
origin |
|
Germline Transmission:
|
Earliest citation of germline transmission:
J:121855
|
|
Parent Cell Line:
| R1 (ES Cell) |
|
Strain of Origin:
|
(129X1/SvJ x 129S1/Sv)F1-Kitl+
|
|
Mutation
description |
|
Allele
Type: | |
Targeted (Floxed/Frt) |
|
Mutation: | |
Insertion |
| |
|
A G4595A mutation was introduced into exon 36. The construct included an frt-flanked neo cassette. (J:121855)
|
|
Phenotypes
|
View phenotypes for all genotypes (concatenated display).
|
|
Disease models
|
|
| Find Mice (IMSR) |
Mouse strains and cell lines available from the
International Mouse Strain Resource
(IMSR)
|
| References |
|
Original: |
J:121855
Rodgers KD et al.,
"Reduced perlecan in mice results in chondrodysplasia resembling Schwartz-Jampel syndrome."
Hum Mol Genet 2007 Mar 1;16(5):515-28
|
|
All: |
2 reference(s)
|
|
Analysis Tools
